How Do I Get GLP-1 Medications for Weight Loss?

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Four steps, in order: confirm which approved indication applies to you, get evaluated by a licensed clinician, resolve how you are paying, and verify the pharmacy that dispenses. Skipping the first step is the most common reason the process stalls, because the products people name are often the wrong ones — Ozempic and Mounjaro are type 2 diabetes products, while Wegovy, Zepbound, Saxenda and Foundayo (orforglipron, approved April 1, 2026) carry the chronic weight management indications.

Step One: Match Yourself to an Indication

Wegovy covers weight reduction and long-term maintenance in adults and pediatric patients 12 and older with obesity, and adults with overweight plus at least one weight-related comorbid condition. Zepbound covers chronic weight management on the same structural basis, plus moderate to severe obstructive sleep apnea in adults with obesity.

The pivotal trials enrolled adults with a body mass index of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbid condition such as treated or untreated dyslipidemia or hypertension.

If you have established cardiovascular disease, obstructive sleep apnea or noncirrhotic MASH with moderate to advanced fibrosis, say so explicitly. Each maps to a distinct approved indication that is not a weight-reduction claim, and that distinction can change both the product and the coverage analysis.

Step Two: Get Properly Evaluated

A real intake covers medical history, current medications and supplements, allergies, measured height and weight, weight-related diagnoses and family history. The last item matters because a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 is a labeled contraindication for both semaglutide and tirzepatide products.

It should also cover pancreatitis history, gallbladder disease, diabetic retinopathy, severe gastroparesis, pregnancy status and concurrent insulin or sulfonylurea use, which raises hypoglycemia risk.

This can happen in person or by telehealth. The FDA lists among its warning signs any company that does not require screening and a prescription by a licensed clinician before providing medicine, or that has no licensed clinician available to answer questions afterwards.

Step Three: Resolve the Money Before You Start

Ask your plan in writing whether anti-obesity medications are an excluded benefit under your specific policy. An exclusion cannot be appealed on clinical grounds; a medical-necessity denial can, and missing-documentation denials in particular are frequently reversed.

For Medicare drug coverage, federal regulation identifies agents used for anorexia, weight loss, or weight gain among categories that may be excluded, while a product prescribed against a non-weight indication is assessed on that indication instead.

If coverage is unavailable, the realistic routes are manufacturer savings and direct-purchase programs, older generic oral anti-obesity agents, or a cash-pay compounded preparation — which is a separate regulatory category rather than a covered alternative.

Step Four: Verify Who Is Dispensing

Ask which pharmacy fills the prescription and confirm the licence with your state board of pharmacy. For a compounded preparation, ask whether the base form of semaglutide is used. The FDA states that semaglutide sodium and semaglutide acetate are different active ingredients from the approved drug's and that it is not aware of any lawful basis for their use in compounding.

Ask about potency and sterility testing and about beyond-use dating. Compounded preparations do not undergo premarket review, so the testing regime is a property of the individual pharmacy and its state oversight. PlexusDx works only with licensed 503A compounding pharmacies.

On delivery, check the packaging against the FDA's published warning signs, and note that injectable GLP-1 drugs require refrigeration as stated in their package inserts — the agency recommends not using any that arrive warm or insufficiently refrigerated.

What to Expect Once You Start

A stepwise escalation exists in the labeling to manage tolerability, and its pace is a prescriber decision. Gastrointestinal adverse reactions are the most common in this class and the most common reason people stop, so early follow-up matters.

Both weight-management indications are written as adjuncts to a reduced-calorie diet and increased physical activity. Protein adequacy and resistance training matter for preserving lean mass as total intake falls, and a registered dietitian referral is a normal part of care.

Plan on a horizon of a year or more. The pivotal trials measured outcomes at 68 and 72 weeks, and Wegovy's indication explicitly includes maintaining weight reduction long term.

Common Mistakes to Avoid

Naming a diabetes-only brand for a weight concern, which forces the conversation to be redirected before it can start. Treating an eligibility quiz as an evaluation. Assuming coverage without checking the exclusion question.

Buying outside the prescription system. The FDA has warned about counterfeit Ozempic, illegally marketed semaglutide and tirzepatide, and products falsely labeled "for research purposes" or "not for human consumption" sold to consumers with dosing instructions.

And planning for three months. Randomised withdrawal trials across this class consistently show substantial weight regain after discontinuation, so a short funding runway tends to return you to where you started.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the first step to getting a GLP-1 for weight loss?

Confirming which approved indication applies to you. Wegovy, Zepbound, Saxenda and Foundayo carry chronic weight management indications; Ozempic, Mounjaro and Rybelsus are type 2 diabetes products. Naming the wrong product is the most common reason the process stalls, because prescribers and payers both work from the approved indication rather than the active ingredient.

Can I do this entirely through telehealth?

Yes, when a licensed clinician evaluates you and a state-licensed pharmacy dispenses. The FDA's instruction is to obtain a prescription from your doctor and fill it at a state-licensed pharmacy. Its warning signs include any company that does not require screening and a prescription by a licensed clinician, or that has no clinician reachable after you receive medication.

What will the clinician need from me?

Measured height and weight over time rather than estimates, prior weight loss attempts and their outcomes, a full medication and supplement list, allergies, every weight-related diagnosis you carry, and family history covering thyroid cancer and endocrine neoplasia. That last item screens for a labeled contraindication shared by semaglutide and tirzepatide products.

How long does the process usually take?

The clinical evaluation can be quick; coverage adjudication is what adds time. Prior authorization requires documentation submission and review, and a denial adds an appeal cycle with strict deadlines. Cash-pay routes bypass that step entirely, which is why they are faster rather than clinically different.

What if my insurance will not cover it?

Ask first whether anti-obesity medications are an excluded benefit, since an exclusion is not appealable on clinical grounds. If it is, the realistic routes are manufacturer savings and direct-purchase programs, older generic oral anti-obesity agents, or a cash-pay compounded preparation — which is not FDA-approved and is not a generic version of any brand.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.